This is, at least for now, a relatively small market. Illumina acquired the company manufacturing these chips for $100M. Analysis of a genome in the cloud generally costs below $10 on general purpose hardware.
It is of course possible that these chips enable analyses that are currently not possible/prohibited by cost, but at least for now, this will not be the limiting factor for genomics, but cost of sequencing (which is currently $400-500 per genome)
It is of course possible that these chips enable analyses that are currently not possible/prohibited by cost, but at least for now, this will not be the limiting factor for genomics, but cost of sequencing (which is currently $400-500 per genome)